CNS Drugs Journal Issues Research Articles in April 2022 Edition
April 10, 2022
April 10, 2022
CHAM, Switzerland, April 10 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its April 2022 edition:
* Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis
* Role of Pharmacogenomics in Individualiz . . .
* Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis
* Role of Pharmacogenomics in Individualiz . . .